Co-Authors
This is a "connection" page, showing publications co-authored by Lisa Ng and Laurent Renia.
Connection Strength
5.102
-
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir. Front Immunol. 2021; 12:680188.
Score: 0.238
-
A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients. STAR Protoc. 2021 09 17; 2(3):100671.
Score: 0.238
-
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2. EMBO Mol Med. 2021 06 07; 13(6):e14045.
Score: 0.237
-
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant. Clin Transl Immunology. 2021; 10(2):e1241.
Score: 0.233
-
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19. Cell Rep Med. 2021 02 16; 2(2):100193.
Score: 0.231
-
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun. 2020 10 16; 11(1):5243.
Score: 0.227
-
Systematic analysis of disease-specific immunological signatures in patients with febrile illness from Saudi Arabia. Clin Transl Immunology. 2020; 9(8):e1163.
Score: 0.225
-
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020 08 29; 396(10251):603-611.
Score: 0.225
-
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity. EBioMedicine. 2020 Aug; 58:102911.
Score: 0.223
-
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020 06 01; 11(1):2806.
Score: 0.221
-
The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 06; 20(6):363-374.
Score: 0.220
-
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control. Front Immunol. 2020; 11:879.
Score: 0.220
-
Fast Tracks and Roadblocks for Zika Vaccines. Vaccines (Basel). 2018 Nov 21; 6(4).
Score: 0.199
-
Multimodal assessments of Zika virus immune pathophysiological responses in marmosets. Sci Rep. 2018 11 20; 8(1):17125.
Score: 0.199
-
Plasmodium co-infection protects against chikungunya virus-induced pathologies. Nat Commun. 2018 09 25; 9(1):3905.
Score: 0.197
-
Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity. Sci Rep. 2018 01 30; 8(1):1860.
Score: 0.188
-
Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria. Cell Microbiol. 2018 05; 20(5):e12819.
Score: 0.188
-
Co-infection with Chikungunya virus alters trafficking of pathogenic CD8+ T cells into the brain and prevents Plasmodium-induced neuropathology. EMBO Mol Med. 2018 01; 10(1):121-138.
Score: 0.187
-
Zika Virus Infects Human Fetal Brain Microglia and Induces Inflammation. Clin Infect Dis. 2017 Apr 01; 64(7):914-920.
Score: 0.178
-
Fingolimod treatment abrogates chikungunya virus-induced arthralgia. Sci Transl Med. 2017 02 01; 9(375).
Score: 0.176
-
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis. 2012 Apr 01; 205(7):1147-54.
Score: 0.125
-
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis. 2021 11 02; 73(9):e2932-e2942.
Score: 0.061
-
The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study. Eur Heart J Cardiovasc Pharmacother. 2021 05 23; 7(3):e48-e51.
Score: 0.059
-
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study. EBioMedicine. 2021 Apr; 66:103319.
Score: 0.059
-
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect Dis. 2021 Jun; 8(6):ofab156.
Score: 0.059
-
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021 03 23; 10.
Score: 0.058
-
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe. 2021 Jun; 2(6):e240-e249.
Score: 0.058
-
COVID-19 vaccines and kidney disease. Nat Rev Nephrol. 2021 05; 17(5):291-293.
Score: 0.058
-
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021 01; 17(1):46-64.
Score: 0.057
-
Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa375.
Score: 0.056
-
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Clin Transl Immunology. 2020; 9(7):e1160.
Score: 0.056
-
Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunology. 2020; 9(7):e1159.
Score: 0.056
-
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut. mSphere. 2017 Jul-Aug; 2(4).
Score: 0.046
-
Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus-Infected Patients in Brazil. J Infect Dis. 2017 07 15; 216(2):172-181.
Score: 0.045